While EC-70124 treatment caused a decrease in cell viability of primary FLT3-ITDWT AML patient cells (Figure 1h), the effect was much less pronounced than that observed in FLT3-ITDMUT cells (Figure 1b). This evidence concerns the gene FLT3 and acute myeloid leukemia.